Skip to main content
Signal8

Envoy Medical, Inc. (COCHW)

Specializing in auditory health, Envoy Medical, Inc. crafts medical technologies designed to address the full spectrum of hearing impairment. Its comprehensive suite of products features personal sound amplifiers, conventional hearing aids, the Esteem fully implanted active middle ear device, auditory osseointegrated implants, and Acclaim cochlear implants. Established in 1995, this White Bear Lake, Minnesota-based company rebranded from Envoy Medical Corporation to Envoy Medical, Inc. in September 2023.

Sector: Orthopedic, Prosthetic & Surgical Appliances & Supplies

Industry: Medical - Devices

Envoy Medical, Inc. logo

Envoy Medical, Inc.

NASDAQ:COCHWSub-class of COCHHealthcare
+1.58%$0.0257
CLOSED
Mkt Cap$199K
Float-
O/S7.74M
VOL59K sh
$ Vol$2K
RVOL3.22×
Inst Own-
SI0.1%
Dilution
Envoy Medical, Inc. logoNASDAQ:COCHWClosed$0.0257+1.58%
Pipeline4 lead-sponsored trials·1 active3 completed

Trials need funding. See this company's dilution risk and cash position.

Clinical Trials
Status
  • Not applicable
    Completed

    Esteem Totally Implantable Hearing System

    Esteem Totally Implantable Hearing System

    Mild to Severe Sensorineural Hearing Loss

    Enrollment
    57
    Start
    Jan 2008
    Primary Completion
    Jul 2009
    Completion
    Aug 2010
    NCT01092910
  • Observational
    Completed

    The Esteem® Hearing Implant Post Approval Study

    The Esteem Hearing Implant

    Hearing Loss

    Enrollment
    51
    Start
    Aug 2010
    Primary Completion
    Aug 2014
    Completion
    Mar 2015
    NCT02666222
  • Not applicable
    Completed

    Esteem New Subject Enrollment Post Approval Study

    Implantation of Esteem

    Sensorineural Hearing Loss

    Enrollment
    117
    Start
    Aug 2010
    Primary Completion
    Sep 2021
    Completion
    Sep 2021
    NCT02689349
  • Not applicable
    Active, not recruiting

    Pivotal Clinical Trial Evaluating the Safety and Efficacy of the Fully Implanted Acclaim Cochlear Implant

    Acclaim Cochlear Implant

    Sensori-Neural Deafness, Sensorineural Hearing Loss +4

    Enrollment
    56
    Start
    Feb 2025
    Primary Completion
    Apr 2027est.
    Completion
    Apr 2028est.
    NCT06699797